The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas.
about
EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastomaGlioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotypeConsensus on the role of human cytomegalovirus in glioblastomaImmunotherapy for primary brain tumors: no longer a matter of privilegeImmunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance.Assessing the role of STAT3 in DC differentiation and autologous DC immunotherapy in mouse models of GBMA novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesisPreclinical characterization of signal transducer and activator of transcription 3 small molecule inhibitors for primary and metastatic brain cancer therapyCyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axesCelecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells.Signal transducer and activator of transcription 3 (STAT3) promoter methylation and expression in pituitary adenomaGlioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathwayShort hairpin RNA-mediated fibronectin knockdown delays tumor growth in a mouse glioma model.Efficacy and safety/toxicity study of recombinant vaccinia virus JX-594 in two immunocompetent animal models of glioma.Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growthLong-term safety issues of iPSC-based cell therapy in a spinal cord injury model: oncogenic transformation with epithelial-mesenchymal transition.Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosisImmune therapeutic targeting of glioma cancer stem cells.Glioma cancer stem cells induce immunosuppressive macrophages/microglia.Adenovirus-mediated delivery of bFGF small interfering RNA reduces STAT3 phosphorylation and induces the depolarization of mitochondria and apoptosis in glioma cells U251.Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.The expression of p-STAT3 in stage IV melanoma: risk of CNS metastasis and survival.Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A EpendymomaSignal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.Immunosuppressive mechanisms in glioblastoma.STAT1 gene expression is enhanced by nuclear EGFR and HER2 via cooperation with STAT3PD-L1 expression and prognostic impact in glioblastoma.Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastomaThe role of JAK-STAT signaling within the CNS.Prioritization schema for immunotherapy clinical trials in glioblastoma.Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis.miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of gliomamiR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis.Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma.yuDetecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients.Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas.NF-kappaB and STAT3 signaling in glioma: targets for future therapies
P2860
Q24338526-71E70783-C209-40B6-989D-92741E53E526Q24631473-61EAC1C0-9025-4830-9269-7939B6F8F116Q24632103-0BDDDF69-907F-4C7B-81E1-DBE8E68FBA84Q27002510-78626DB9-3075-48C3-9FC9-32D676C64275Q28078539-72AB3C52-AB8C-46A8-90AB-558C70771018Q30456087-8AFAC486-A60F-4A75-AB2A-30CBF8B9D9D4Q33578030-B068EB46-A418-4C8F-83E1-EAF53BEEA388Q33597235-5CCD658B-F5D1-4F33-9A83-E0DF7237BA41Q33603599-8A23A69F-5AC8-45FC-96F1-620706DA17F9Q33669979-3513ECCA-76EE-4C57-B55B-B84B177B2015Q33907955-6C73FDF3-3D2A-4DA9-99F3-931B5A71C7B8Q33910722-618591E3-5CF8-403F-91B3-582A6AD6ABDEQ34129168-1078B470-BBA2-4262-8246-537AC5C96D1BQ34177244-438EB3AA-F768-47A2-B7A5-760DEB071D5EQ34343768-2E174C8C-0750-4D1A-BCC1-A6974CB0FD2AQ34393758-5D8E0E48-7CF8-4382-AC79-3D9A7F622CE3Q34457728-0723676F-33F1-42D4-860E-9A933975FF67Q34462874-1C5A082F-BD0E-4F9C-99D3-AA1360BF8211Q34536056-2BF6E619-C7CE-4B92-9757-522A82B27270Q34676437-350BC1EB-2A11-421E-8C3A-E43CD4C855FCQ34992518-00B2C820-90B4-4C36-B95C-526A675E3FB3Q35230410-CA8FB08F-C2A9-4AD6-A595-238B70558F13Q35587235-F7CE87AF-962D-43C9-87F2-3CBE7AB9E400Q35674906-5F938849-E9A1-4CBD-A49C-6824685B1AB7Q35987091-CB8F7BE5-E5BE-4EA6-802A-66D8BFC0003AQ36132647-A0558F8A-D896-47DD-BAB3-E376C7112C6CQ36179166-DEAA3AA4-DB79-45B4-BB2A-FB4F08736E54Q36224048-ABAAA671-6DB9-4903-BCC1-593847C7B63CQ36351195-E2D95C39-2FEE-430C-9C32-65670A37293DQ36493843-A93C7DAF-F9BB-4A77-933C-349DD473814AQ36862759-D4EAAC0E-34BC-4C53-9376-FFB18BA4C93EQ36895415-7961978F-FB6E-44EB-931D-B5C2E7D17C30Q37078999-CAD6E8E0-AFE1-40E6-A90E-F141D5E7E7F1Q37190200-8529E833-E534-4A3F-8AA5-A98923CA8ACCQ37191655-1D5BBAA5-F2F4-4A7F-BA4A-6E8B0F058CC9Q37276897-94FE67CE-FB45-4E2D-BF75-9FA074583F20Q37301799-4FBFDB74-81E3-43DD-8E23-884CC6948AE5Q37420546-48130EE4-27ED-4853-B274-B8A8436BE994Q37435455-D39C358D-1DE4-420D-AB19-BBB8BD159ABFQ37457873-3757A01A-4DEB-48E0-BF7C-329B4DE56653
P2860
The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The incidence, correlation wit ...... 3 expression in human gliomas.
@en
The incidence, correlation wit ...... 3 expression in human gliomas.
@nl
type
label
The incidence, correlation wit ...... 3 expression in human gliomas.
@en
The incidence, correlation wit ...... 3 expression in human gliomas.
@nl
prefLabel
The incidence, correlation wit ...... 3 expression in human gliomas.
@en
The incidence, correlation wit ...... 3 expression in human gliomas.
@nl
P2093
P2860
P1476
The incidence, correlation wit ...... T3 expression in human gliomas
@en
P2093
Amy B Heimberger
David S Yang
Ling-Yuan Kong
Mohamed Abou-Ghazal
Nobuyoshi Hiraoka
Raymond Sawaya
Waldemar Priebe
P2860
P304
P356
10.1158/1078-0432.CCR-08-1329
P407
P577
2008-12-01T00:00:00Z